European Deep Tech Spinouts Hit $1B Valuations in 2025

European deep tech university spinouts are experiencing a significant boom, solidifying their position as a vital engine for innovation. A new report from Dealroom highlights that nearly 80 such ventures have achieved remarkable financial milestones, attracting substantial venture capital (VC) funding.

According to Dealroom's European Spinout Report 2025, 76 deep tech and life sciences companies originating from European universities and research labs have either reached $1 billion valuations, $100 million in revenue, or both. This success has transformed academic spinouts into a robust startup funnel valued at $398 billion, drawing increased interest from investors. Notable unicorns emerging from this ecosystem include Iceye, IQM, Isar Aerospace, Synthesia, and Tekever, whose achievements are now inspiring more funds to back university-derived companies.

The growing appetite for these ventures is evident in the emergence of new dedicated funds. Just this month, two new initiatives launched to inject more capital into talent emerging from European tech universities, expanding a pipeline traditionally dominated by institutions like Cambridge, Oxford, and ETH Zurich.

• Denmark-based PSV Hafnium recently closed its inaugural fund at an oversubscribed €60 million (approximately $71 million), with a strategic focus on Nordic deep tech.
• U2V (University2Ventures), with offices in Berlin, London, and Aachen, is targeting the same amount for its first fund, having recently completed its first closing.

These newcomers join a burgeoning group of European venture firms that prioritize university spinouts in their investment strategies. While pioneers like Cambridge Innovation Capital and Oxford Science Enterprises have matured, the category has diversified. It now includes not only funds backed by universities but also independent firms that recognize spinouts as significant potential return generators. A prime example is Oxford Ionics, a spinout from the University of Oxford, which was acquired by U.S.-based IonQ, contributing to the six spinout exits from Switzerland, the U.K., and Germany that delivered over $1 billion to investors in 2025.

These successful exits coincide with a surge in funding. European university spinouts in deep tech and life sciences are on track to raise a near all-time-high of $9.1 billion in 2025, according to Dealroom. This stands in stark contrast to the overall VC funding landscape in Europe, which has seen a nearly 50% decline from its 2021 peak.

Large funding rounds in 2025 further underscore investor confidence across diverse sectors, from nuclear energy with Proxima Fusion to dual-use drones with Quantum Systems, now valued above $3 billion. Many of these startups leverage specialized lab research, explaining the wide geographical distribution of European locations capable of producing successful spinouts.

Building relationships with hubs beyond traditional centers like Oxbridge and leading countries offers new funds a way to differentiate and discover deals. PSV Hafnium's partners, for instance, stated in a press release that "The Nordics’ research institutions hold extraordinary, untapped potential." PSV Hafnium itself is a spinout from the Technical University of Denmark (DTU) and is actively making early-stage investments across Nordic countries. One of its nine investments to date went to SisuSemi, a Finnish startup utilizing a decade of research from the University of Turku to develop new surface cleaning technology for the semiconductor industry.

While increased funding, alongside grants, commercialization support, and improved deal terms, creates an encouraging environment for Europe's spinouts, one significant challenge persists: access to growth capital. As the report's authors note, this funding gap is not unique to spinouts but impacts the entire European startup ecosystem. However, it is particularly striking that nearly 50% of late-stage funding for European deep tech and life sciences spinouts originates from outside Europe, primarily the U.S.

Although this share has decreased over the years, Europe will not fully reap the benefits of its substantial investments in talent and research until this trend shifts more substantially. Addressing this broader issue of securing more domestic growth capital remains crucial for the continent's long-term innovation success.